Active Clinical Trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.
- Sort by Sort ascending
- Study title
- Condition
- Phase
- Location
- NCT ID
| Study title | Condition | Phase | Location | NCT ID |
|---|---|---|---|---|
Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With Schizophrenia |
Schizophrenia | Phase2 | Bulgaria United States |
NCT07467993 |
A Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental Vitiligo |
Non-segmental Vitiligo | Phase2 | Argentina Australia Canada China France Germany India Italy Japan Netherlands Spain United States View all |
NCT07431177 |
A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease |
Huntington Disease | Phase3 | Argentina Australia Belgium Bulgaria Canada China Colombia Czechia Denmark France Germany Hungary Israel Italy Japan Netherlands Poland Portugal Romania Saudi Arabia Slovakia South Korea Spain Switzerland Taiwan United Kingdom United States View all |
NCT07326709 |
A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration |
Geographic Atrophy Secondary to Age-related Macular Degeneration | Phase2 | Argentina Australia Brazil Bulgaria Canada Colombia Czechia France Germany Hungary Italy Japan Poland Puerto Rico Romania Spain United Kingdom United States View all |
NCT07441642 |
Regulatory Post-Marketing Surveillance in Hidradenitis Suppurativa, Pediatric Plaque Psoriasis and JIA Treated With Cosentyx®(Secukinumab) in Korea |
Hidradenitis Suppurativa, Pediatric Plaque Psoriasis, Juvenile Idiopathic Arthritis | South Korea | NCT07243782 | |
Real-world Use of Lutetium (177Lu) Vipivotide Tetraxetan in China(PSMAreal CN) |
Metastatic Prostate Cancer | China | NCT07290270 | |
A NIS Evaluating Various Injectable and Oral Treatments in Patients With Relapsing Multiple Sclerosis |
Relapsing Multiple Sclerosis | Germany | NCT05344469 | |
Remibrutinib in Real-world Clinical Practice - a US Sub-study |
Chronic Spontaneous Urticaria | United States | NCT07358780 | |
A Real-world Study of Remibrutinib in Chronic Spontaneous Urticaria Patients |
Chronic Spontaneous Urticaria | United States | NCT07408219 | |
Remibrutinib in Real-world Clinical Practice |
Chronic Spontaneous Urticaria | United States | NCT07358364 |